In tumours, the status of several autophagy proteins, such as LC3b, ATG5, Beclin1 and its interacting proteins high mobility group Box 1 (HMGB1) and the Bcl-2-family, mostly assessed using immunohistochemistry, has been evaluated as a marker in several tumour types. Here, BCL2 is linked to neoplasm.